Galapagos NV (NASDAQ:GLPG)

231.36
Delayed Data
As of Jan 24
 -0.74 / -0.32%
Today’s Change
94.75
Today|||52-Week Range
242.38
+11.86%
Year-to-Date
Which Big Biotech Has the Safer Dividend -- Amgen or Gilead Sciences?
7:30am / MotleyFool.com - Paid Partner Content
Better Buy: Vertex Pharmaceuticals vs. Galapagos
Jan 25 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close232.10
Today’s open237.80
Day’s range231.14 - 238.43
Volume184,600
Average volume (3 months)132,920
Market cap$14.3B
Data as of 4:00pm ET, 01/24/2020

Growth & Valuation

Earnings growth (last year)+75.16%
Earnings growth (this year)+1,021.35%
Earnings growth (next 5 years)+46.38%
Revenue growth (last year)+135.28%
P/E ratio42.9
Price/Sales14.03
Price/Book9.08

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+2.04+1.73%
INCYIncyte Corp-1.50-1.92%
MYLMylan NV-0.29-1.31%
BHCValeant Pharmaceutic...-0.79-2.71%
Data as of 6:30pm ET, 01/24/2020

Financials

Next reporting dateFebruary 20, 2020
EPS forecast (this quarter)$0.04
Annual revenue (last year)$340.8M
Annual profit (last year)-$34.5M
Net profit margin-10.13%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Mechelen, Brussels Region

Forecasts